ETHAMSYLATE
Background and Date of Approval
Ethamsylate is a haemostatic agent indicated for prevention and control of abnormal bleeding. Approved for medical use from the 1970s, it functions by strengthening capillary walls and reducing bleeding time. Clinical trials have demonstrated its efficacy in managing haemorrhagic conditions, particularly in gynaecological and surgical settings. Due to its targeted mechanism of action and relatively low incidence of adverse effects, Ethamsylate continues to serve as an important therapeutic option for managing blood loss across various clinical scenarios.
Uses
Ethamsylate is FDA-approved for managing various bleeding disorders, including: Abnormal uterine bleeding (e.g., menorrhagia) Postoperative hemorrhage Bleeding associated with dental procedures Capillary bleeding in general surgery Nosebleeds (epistaxis)
How is it administered?
Ethamsylate is available in oral tablet form, injectable solutions, and topical preparations. The typical dosage is: Adults: 500mg to 1g every 6 to 8 hours, depending on the condition and severity. Children: Dosage varies based on body weight and age, usually administered under strict medical supervision. Administration should follow the healthcare providerâs instructions, with adjustments made for specific conditions or patient needs.
Side Effects
Common Side Effects Nausea and vomiting Skin rash or itching Mild headache Dizziness Serious Side Effects Severe allergic reactions (e.g., swelling, difficulty breathing) Gastrointestinal disturbances Elevated liver enzymes (rare) Hypotension or changes in heart rate
Warnings
Severe Allergic Reactions: Avoid in patients with known hypersensitivity to the drug. Drug Interactions: Potential interaction with anticoagulants and antiplatelet agents. Pregnancy and Lactation: Use only if clearly necessary under medical advice. Bleeding Disorders: Not suitable for use in conditions requiring systemic anticoagulation therapy.
Precautions
Before using Ethamsylate, it is crucial to evaluate the underlying cause of bleeding. Ensure that it is not a substitute for treating the primary condition causing blood loss. Pregnant and breastfeeding women should consult a healthcare provider before use. Regular monitoring is advised in patients with a history of cardiovascular conditions or coagulopathies. Always adhere to prescribed dosages to minimise risks.
Word of Advice
Ethamsylate must be taken according to your healthcare provider's instructions. Do not self-medicate, particularly if you are taking other blood-thinning or anticoagulant medications. Maintain adequate hydration and report any unusual symptoms, including persistent bleeding or severe dizziness, to your doctor during treatment. For optimal therapeutic effect, complete the full prescribed course as directed, even if your symptoms improve before finishing the medication.
References
https://www.ema.europa.eu/en/documents/mrl-report/etamsylate-summary-report-committee-veterinary-medicinal-products_en.pdf https://pubmed.ncbi.nlm.nih.gov/16772766/ https://pubchem.ncbi.nlm.nih.gov/compound/Ethamsylate https://www.pediatriconcall.com/drugs/ethamsylate/557 https://www.sciencedirect.com/topics/pharmacology-toxicology-and-pharmaceutical-science/etamsylate
Frequently Asked Questions
What is Ethamsylate used for?
Ethamsylate is used to prevent and manage abnormal bleeding, such as heavy menstrual bleeding, postoperative haemorrhage, and capillary bleeding during surgeries or injuries.
When should I take Ethamsylate?
It is usually taken as prescribed by your doctor, often every 6-8 hours. Follow the schedule provided for maximum effectiveness.
Can I take Ethamsylate with food?
Yes, Ethamsylate can be taken with or without food. However, taking it after meals may help reduce potential stomach discomfort.
Does Ethamsylate stop periods?
No, Ethamsylate doesnât stop periods. It helps reduce excessive menstrual bleeding by stabilising capillaries and promoting clot formation.